EA
NVO

Emerald Acquisition’s Novo Nordisk NVO Stock Holding History

Emerald Acquisition’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$13.9M Buy
+666,610
New +$16.5M 0.03% 697

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Emerald Acquisition's NVO Position: Q3 2016 in Review

Emerald Acquisition opened a new position in Novo Nordisk (NVO) in Q3 2016: 666,610 shares worth $13.9M. The stake represents 0.03% of the portfolio and ranks #697 among its holdings.

511 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

  • Emerald Acquisition held 666,610 shares of Novo Nordisk worth $13.9M as of Q3 2016.
  • Novo Nordisk was a new Emerald Acquisition position in Q3 2016.
  • Novo Nordisk made up 0.03% of Emerald Acquisition's portfolio in Q3 2016, its #697 holding.
  • 511 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.